Related Experiment Video
Updated: Mar 8, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Salubrinal protects against Clostridium difficile toxin B-induced CT26 cell death
Shuyi Chen1, Chunli Sun1, Huawei Gu1
1School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Salubrinal protects colon tumor cells from Clostridium difficile toxin B (TcdB) by inhibiting cell death pathways. This study reveals salubrinal
Area of Science:
- Microbiology
- Cell Biology
- Toxicology
Background:
- Clostridium difficile infections (CDI) are increasing globally.
- Toxin B (TcdB) is a key virulence factor in CDI, causing cell death.
- TcdB-induced cell death mechanisms, particularly endoplasmic reticulum stress, are not fully understood.
Purpose of the Study:
- To investigate the protective effect of salubrinal against TcdB-induced cell death in CT26 cells.
- To elucidate the underlying molecular mechanisms of salubrinal's protective action.
Main Methods:
- Utilized CT26 cell line (mouse colon tumor cells).
- Administered TcdB and salubrinal (eIF2α dephosphorylation inhibitor).
- Assessed cell viability, apoptosis, and activation of caspase-9, eIF2α signaling, and autophagy.
Main Results:
- Salubrinal significantly protected CT26 cells from TcdB-induced cytotoxicity and cytopathic effects.
- Salubrinal inhibited TcdB-mediated apoptosis and cell death.
- The protective effect involved the caspase-9-dependent pathway, eIF2α signaling, and autophagy.
Conclusions:
- Salubrinal demonstrates a protective role against TcdB-induced cell death in colon tumor cells.
- The findings highlight the involvement of caspase-9, eIF2α signaling, and autophagy in TcdB toxicity and salubrinal's protective mechanism.
- This research provides potential therapeutic insights for managing CDI.
More Related Videos
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022